Lords Mark bets big on AI-driven dialysis tech, buys 85% stake in Renalyx Health
Renalyx will continue operating as an independent unit within the group
Renalyx will continue operating as an independent unit within the group
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
The partnership will enable rapid and reliable product delivery
Subscribe To Our Newsletter & Stay Updated